TY  - GEN
AU  - Choong,Nicholas W
AU  - Mauer,Ann M
AU  - Haraf,Daniel J
AU  - Lester,Eric
AU  - Hoffman,Philip C
AU  - Kozloff,Mark
AU  - Lin,Shang
AU  - Dancey,Janet E
AU  - Szeto,Livia
AU  - Grushko,Tatyana
AU  - Olopade,Olufunmilayo I
AU  - Salgia,Ravi
AU  - Vokes,Everett E
TI  - Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer
SN  - 1556-1380
PY  - 2008///1204
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Docetaxel
KW  - ErbB Receptors
KW  - genetics
KW  - Erlotinib Hydrochloride
KW  - Etoposide
KW  - Female
KW  - Gene Amplification
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Remission Induction
KW  - Survival Rate
KW  - Taxoids
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1097/JTO.0b013e31818396a4
ER  -